Mia's Feed
Medical News & Research

New insights into intestinal hormone's role in promoting fat burning and weight loss in obese mice

New insights into intestinal hormone's role in promoting fat burning and weight loss in obese mice

Share this article

A groundbreaking study reveals how the intestinal hormone FGF19 activates brain pathways to boost fat burning and promote weight loss in obese mice, opening new therapeutic possibilities for obesity and metabolic disorders.

2 min read

Recent research has shed light on how a hormone produced by the intestine influences energy regulation and fat metabolism, offering promising avenues for obesity treatment. The hormone, known as fibroblast growth factor 19 (FGF19), activates mechanisms that enhance energy expenditure, stimulate fat burning, and help regulate blood glucose levels in obese mice. The study found that FGF19 acts on the hypothalamus, a critical brain region for maintaining energy balance, leading to increased activity of thermogenic fat cells that produce heat and burn calories.

The observed effects include not only improved metabolic functions but also reductions in peripheral inflammation and increased cold tolerance, which are essential for adaptive thermogenesis. Notably, these benefits were dependent on the activity of the sympathetic nervous system, which was shown to be crucial for FGF19's action.

The research team administered FGF19 directly into the brains of obese mice fed a high-fat diet, resulting in increased sympathetic nervous activity and boosted thermogenesis in white and brown adipose tissues. They also analyzed single-cell RNA sequencing data from the hypothalamus, identifying specific cell types that express FGF19 receptors, thus providing insight into the brain pathways involved.

These findings open new possibilities for developing drugs that mimic endogenous compounds like FGF19 to combat obesity and metabolic disorders such as diabetes. For instance, current therapies like semaglutide (Ozempic) operate by activating pathways that promote satiety, and future drugs could also target energy expenditure directly.

Furthermore, the study highlighted that FGF19's role extends beyond appetite regulation; it actively stimulates energy expenditure through thermogenesis, making it a promising target for comprehensive obesity management. The research was published in the American Journal of Physiology—Endocrinology and Metabolism and recognized as a top article in the journal.

Considering global obesity trends and their impact on non-communicable diseases, this discovery offers new hope for innovative treatments and highlights the importance of understanding brain-hormone interactions in energy regulation.

Source: https://medicalxpress.com/news/2025-06-intestinal-hormone-fat-weight-loss.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Study Finds Telehealth Prescriptions for ADHD Do Not Increase Risk of Substance Use Disorders

A groundbreaking study shows that prescribing ADHD medications via telehealth does not increase the risk of substance use disorders, supporting its safe use for treatment accessibility.

Mouse Study Connects Chronic Pain with Altered Sleep Patterns

A groundbreaking mouse model reveals how chronic pain disrupts sleep patterns, offering new insights into pain management and sleep health. Published by Washington University researchers, this study paves the way for targeted treatments to improve quality of life for those with chronic pain.

Major Recall: Over 67,000 Cases of Power Stick Deodorant Sold at Major Retailers

Over 67,000 cases of Power Stick deodorant sold at Dollar Tree, Walmart, and Amazon have been recalled due to manufacturing safety concerns. Consumers are advised to dispose of or return affected products.

UK Issues Warning Against Using 'Skinny Jabs' During Pregnancy and Breastfeeding

The UK raises concerns over the safety of 'skinny jabs' like Ozempic and Wegovy for women trying to conceive, highlighting risks during pregnancy and breastfeeding due to limited safety data. Proper contraception and medical advice are essential.